We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

107 hedge funds and large institutions have $22.2M invested in Inovio Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,018% more call options, than puts

Call options by funds: $436K | Put options by funds: $39K

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

26% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 27

3% more funds holding

Funds holding: 104 → 107 (+3)

0.07% more ownership

Funds ownership: 37.02% → 37.09% (+0.07%)

9% less capital invested

Capital invested by funds: $24.5M → $22.2M (-$2.3M)

Holders
107
Holders Change
+3
Holders Change %
+2.88%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
27
Closed
13
Calls
$436K
Puts
$39K
Net Calls
+$397K
Net Calls Change
+$103K

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$1.33M
2
BlackRock
BlackRock
New York
+$823K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$713K
4
Northern Trust
Northern Trust
Illinois
+$495K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$438K

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$1.2M
2
SCM
Stonepine Capital Management
Oregon
-$1.07M
3
HCM
Highbridge Capital Management
New York
-$549K
4
Renaissance Technologies
Renaissance Technologies
New York
-$394K
5
UOC
UBS O'Connor
Illinois
-$393K
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
76
Amalgamated Bank
New York
$1K – – –
Nisa Investment Advisors
77
Nisa Investment Advisors
Missouri
$981 +$678 +338 +128%
PNC Financial Services Group
78
PNC Financial Services Group
Pennsylvania
$855 +$149 +74 +16%
CA
79
Clearstead Advisors
Ohio
$815 – – –
CWM
80
Crowley Wealth Management
Delaware
$659 – – –
AF
81
Allworth Financial
California
$571 – – –
NFSG
82
Newbridge Financial Services Group
Florida
$543 – – –
MAFA
83
MJT & Associates Financial Advisory
Minnesota
$530 +$652 +325 New
FDCDDQ
84
Federation des caisses Desjardins du Quebec
Quebec, Canada
$500 -$267 -133 -30%
ANBT
85
American National Bank & Trust
Texas
$326 – – –
PS
86
Principal Securities
Iowa
$324 – – –
EWA
87
EverSource Wealth Advisors
Alabama
$319 +$10 +5 +3%
BCM
88
Blume Capital Management
California
$136 – – –
PAI
89
Pittenger & Anderson Inc
Nebraska
$126 – – –
IA
90
IFP Advisors
Florida
$118 – – –
US Bancorp
91
US Bancorp
Minnesota
$116 +$18 +9 +15%
RIL
92
Rothschild Investment LLC
Illinois
$98 +$120 +60 New
National Bank of Canada
93
National Bank of Canada
Quebec, Canada
$86 -$2 -1 -2%
TWC
94
TD Waterhouse Canada
Ontario, Canada
$69 – – –
1NWS
95
1 North Wealth Services
Maryland
$67 +$82 +41 New
Jones Financial Companies
96
Jones Financial Companies
Missouri
$31 -$367 -183 -91%
AP
97
Atwood & Palmer
Missouri
$30 – – –
SIS
98
Strategic Investment Solutions
Illinois
$26 – – –
FFA
99
Farther Finance Advisors
California
$24 -$60 -30 -65%
TIM
100
Thompson Investment Management
Wisconsin
$21 – – –
1 2 3
4
5

INO Hedge Fund Activity: Q1 2025 in Review

107 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q1 2025, worth a combined $22.2M — down 9.4% from $24.5M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new INO positions and 13 closed out — a net gain of 4 holders — while 34 added to existing stakes and 27 trimmed.

The largest buyer was Bank of America, adding an estimated $1.33M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $1.2M sold.

  • 107 institutional investors held Inovio Pharmaceuticals (INO) as of Q1 2025, up from 104 in Q4 2024.
  • Funds reported $22.2M of Inovio Pharmaceuticals stock for Q1 2025, down 9.4% quarter-over-quarter.
  • 17 funds opened new Inovio Pharmaceuticals positions in Q1 2025 and 13 closed out, a net change of +4 holders.
  • The largest Inovio Pharmaceuticals buyer in Q1 2025 was Bank of America, an estimated $1.33M added.
  • The largest Inovio Pharmaceuticals seller in Q1 2025 was AIGH Capital Management, an estimated $1.2M sold.

Based on aggregated 13F filings for Q1 2025.